A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Intima Bioscience, Inc.
Intima Bioscience, Inc.
NantCell, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Palleon Pharmaceuticals, Inc.
Hoffmann-La Roche
NuCana plc
Intensity Therapeutics, Inc.
PureTech
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
NantBioScience, Inc.
Augusta University
National Institutes of Health Clinical Center (CC)
Klus Pharma Inc.
H. Lee Moffitt Cancer Center and Research Institute
Gilead Sciences
Gilead Sciences
University of Arkansas
Roswell Park Cancer Institute
University of Louisville
SillaJen, Inc.
Isofol Medical AB
Jonsson Comprehensive Cancer Center
Brown University
University of Leicester
Stanford University
Surgimab
Swiss Cancer Institute
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
MediGene
Precision Biologics, Inc
University of British Columbia
Memorial Sloan Kettering Cancer Center
Medical University of Vienna
Corporal Michael J. Crescenz VA Medical Center
National Research Council, Spain
National Cancer Institute (NCI)
University Hospital, Basel, Switzerland
Arya, Vijaypal, M.D., P.C.
National Cancer Institute (NCI)
Amgen
Amgen
University of Chicago
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center